Results 71 to 80 of about 2,865 (96)
Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial. [PDF]
Nat MedHouot R, Bachy E, Cartron G, Gros FX, Morschhauser F, Oberic L, Gastinne T, Feugier P, Duléry R, Thieblemont C, Joris M, Jardin F, Choquet S, Casasnovas O, Brisou G, Cheminant M, Bay JO, Gutierrez FL, Menard C, Tarte K, Delfau MH, Portugues C, Itti E, Palard-Novello X, Blanc-Durand P, Al Tabaa Y, Bailly C, Laurent C, Lemonnier F. +28 moreeuropepmc +1 more sourcePAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome. [PDF]
J Clin MedBeck DB, Heiblig M, Savic S, Ferrada MA, Mekinian A, Chowdhury O, Hammond D, Weeks LD, Gurnari C, Kirino Y, Georgin-Lavialle S, Buckley SA, Garcha R, Harder BG, Koster MJ. +14 moreeuropepmc +1 more sourceHigher levels of host-cell DNA methylation markers ZNF582 and ASCL1 on anal smears are predictive for progression to anal cancer in patients with previous high-grade lesions. [PDF]
EBioMedicineFerré VM, Dupont A, Draullette M, Valette E, Collin G, Bucau M, Siproudhis L, Staumont G, Roy C, Hesselink AT, Bouchard D, Radenne S, Spindler L, Naji A, Bergeron C, Couvelard A, Descamps D, Steenbergen RDM, Charpentier C, Abramowitz L, AIN3 National Cohort, GREP. +21 moreeuropepmc +1 more sourceAssociations between frailty, biomarkers of cerebral pathology, cognitive and neuropsychiatric symptoms: a memory clinic study. [PDF]
J Frailty AgingGilles V, Flaus A, Teillac A, Verny M, Blanc F, Paccalin M, Desmidt T, Louchart de la Chapelle S, Dumay C, Sauvée M, Lehmann S, Hirtz C, Cotton F, Bathsavanis A, Gervais F, Novais T, Desestret V, Boublay N, Krolak-Salmon P, Dautricourt S, Garnier-Crussard A. +20 moreeuropepmc +1 more sourcePostoperative SBRT and Severe Late Toxic Effects in Early-Stage Oropharyngeal and Oral Cavity Cancers: The STEREOPOSTOP-GORTEC 2017-03 Nonrandomized Clinical Trial.
JAMA Netw OpenBiau J, Sun X, Liem X, Faivre JC, Eker E, Blanchard P, Tao Y, Doré M, Maingon P, Vulquin N, Alfonsi M, Thureau S, Huguet F, Racadot S, Thivat E, Molnar I, Boisselier P, Guihard S, Gallocher O, Dupin C, Batard S, Bourhis J, Lapeyre M. +22 moreeuropepmc +1 more sourceSome of the next articles are maybe not open access.
